Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Link Medical Products Pty Ltd T/A Link Pharmaceuticals

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (75)
Cancellation by sponsor (43)
Prescription medicine registration (6)
Designation or determination (4)
Australian Public Assessment Report (AusPAR) (1)
Prescription medicine evaluation (1)

Date

2024 (1)
2023 (32)
2022 (10)
2021 (11)
2020 (7)
2019 (3)
2018 (3)
2017 (10)
2016 (4)
2015 (11)
2014 (2)
2013 (2)
2012 (5)
2009 (2)
2008 (1)
2005 (2)
2004 (2)
2001 (2)
2000 (2)
1998 (3)
1997 (3)
1996 (1)
1994 (2)
1993 (1)
1992 (1)
1991 (7)

Results for "[search-keyword]"

Search

Sponsor content

130 result(s) found, displaying 41 to 50

TRECONDI (Link Medical Products Pty Ltd T/A Link Pharmaceuticals)

19 September 2022

Prescription medicine registration

Active ingredients: treosulfan.
KAMRAB rabies immunoglobulin 150 IU/mL solution for injection vial (336970)

16 August 2021

ARTG

Australian Register of Therapeutic Goods (ARTG) information for KAMRAB rabies immunoglobulin 150 IU/mL solution for injection vial.
TEPADINA (Link Medical Products Pty Ltd T/A Link Pharmaceuticals)

12 July 2022

Prescription medicine registration

Active ingredients: thiotepa.
AusPAR: Rabies immunoglobulin

11 August 2021

Australian Public Assessment Report (AusPAR)

New AusPAR for KamRAB (rabies immunoglobulin) for the treatment of passive, transient post-exposure prophylaxis of rabies infection.
KAMRAB (Link Medical Products Pty Ltd T/A Link Pharmaceuticals)

11 August 2021

Prescription medicine registration

Active ingredients: rabies immunoglobulin.
VISUDYNE verteporfin 15mg powder for injection vial Cancelled under Section 30(1)(c) of the Act

8 July 2021

Cancellation by sponsor

Requested by Link Medical Products Pty Ltd T/A Link Pharmaceuticals
TREXJECT IN methotrexate (as sodium) 25mg/0.50mL solution for injection pre-filled syringe Cancelled under Section 30(1)(c) of the Act

30 June 2021

Cancellation by sponsor

Requested by Link Medical Products Pty Ltd T/A Link Pharmaceuticals
TREXJECT IN methotrexate (as sodium) 22.5mg/0.45mL solution for injection pre-filled syringe Cancelled under Section 30(1)(c) of the Act

30 June 2021

Cancellation by sponsor

Requested by Link Medical Products Pty Ltd T/A Link Pharmaceuticals
TREXJECT IN methotrexate (as sodium) 20mg/0.40mL solution for injection pre-filled syringe Cancelled under Section 30(1)(c) of the Act

30 June 2021

Cancellation by sponsor

Requested by Link Medical Products Pty Ltd T/A Link Pharmaceuticals
TREXJECT IN methotrexate (as sodium) 17.5mg/0.35mL solution for injection pre-filled syringe Cancelled under Section 30(1)(c) of the Act

30 June 2021

Cancellation by sponsor

Requested by Link Medical Products Pty Ltd T/A Link Pharmaceuticals

Pages

First page
Previous page
Page 1
Page 2
Page 3
Page 4
Current page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.